Toggle navigation
Home
Search
Services
Blog
Contact
About
Novel Screen for Translation - Inhibitory Antifungals
Moehle, Charles M.
Ribogene, Inc., Hayward, CA, United States
Search 3 grants from Charles Moehle
Search grants from Ribogene, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Studies of Motoneuron Death - Insight Into the SMAs and ALS
High Resolution Cervical Carotid Imaging with MR
Intracranial Mapping of Sensory Gating in Humans
Specificity of Heparan Sulfate for Herpes Infection
Building Design Apps for Early Engineering Education
Recently added grants:
The Role of 27-hydroxycholesterol in Breast Cancer: A Population-Based Multiethnic Study
Development of a microfluidic primary cell editing platform (pCEP) for personal gene therapy
Northwestern University Lead Academic Participating Site
UM LAPs - UG1 Grant
UG1 - NCTN (Network Lead)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44AI036730-03
Application #
2073190
Study Section
Special Emphasis Panel (ZRG5-MBC-2 (01))
Project Start
1995-09-15
Project End
1997-08-31
Budget Start
1996-09-01
Budget End
1997-08-31
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Ribogene, Inc.
Department
Type
DUNS #
City
Hayward
State
CA
Country
United States
Zip Code
94545
Related projects
NIH 1996
R44 AI
Novel Screen for Translation - Inhibitory Antifungals
Moehle, Charles M. / Ribogene, Inc.
NIH 1995
R44 AI
Novel Screen for Translation - Inhibitory Antifungals
Moehle, Charles M. / Ribogene, Inc.
Comments
Be the first to comment on Charles Moehle's grant